Home/Filings/4/0001209191-03-029053
4//SEC Filing

KISS ROBERT E 4

Accession 0001209191-03-029053

CIK 0001131907other

Filed

Nov 5, 7:00 PM ET

Accepted

Nov 6, 5:18 PM ET

Size

18.3 KB

Accession

0001209191-03-029053

Insider Transaction Report

Form 4
Period: 2003-11-04
Transactions
  • Conversion

    Common Stock

    2003-11-04+578,417578,417 total(indirect: By Fund)
  • Conversion

    Common Stock

    2003-11-04+165,384165,384 total(indirect: By Fund)
  • Conversion

    Series C Preferred Stock

    2003-11-0470,0440 total(indirect: By Fund)
    Exercise: $8.84Common Stock (70,044 underlying)
  • Conversion

    Common Stock

    2003-11-04+1,58332,575 total(indirect: By Fund)
  • Conversion

    Common Stock

    2003-11-04+244,972823,389 total(indirect: By Fund)
  • Conversion

    Series C Preferred Stock

    2003-11-04244,9720 total(indirect: By Fund)
    Exercise: $8.84Common Stock (244,972 underlying)
  • Conversion

    Common Stock

    2003-11-04+70,044235,428 total(indirect: By Fund)
  • Conversion

    Common Stock

    2003-11-04+30,99230,992 total(indirect: By Fund)
  • Conversion

    Series B Preferred Stock

    2003-11-0430,9920 total(indirect: By Fund)
    Exercise: $9.68Common Stock (30,992 underlying)
  • Conversion

    Series C Preferred Stock

    2003-11-041,5830 total(indirect: By Fund)
    Exercise: $8.84Common Stock (1,583 underlying)
  • Conversion

    Series B Preferred Stock

    2003-11-04578,4170 total(indirect: By Fund)
    Exercise: $9.68Common Stock (578,417 underlying)
  • Conversion

    Series B Preferred Stock

    2003-11-04165,3840 total(indirect: By Fund)
    Exercise: $9.68Common Stock (165,384 underlying)
Footnotes (6)
  • [F1]Not applicable to this transaction.
  • [F2]Held by 522 Fifth Avenue Fund.
  • [F3]The reporting person disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in the named fund, and the inclusion of these shares shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  • [F4]Held by J.P. Morgan Direct Venture Capital Institutional Investors II LLC.
  • [F5]Held by J.P. Morgan Direct Venture Capital Private Investors II LLC.
  • [F6]Immediately convertible.

Issuer

CANCERVAX CORP

CIK 0001131907

Entity typeother

Related Parties

1
  • filerCIK 0001265795

Filing Metadata

Form type
4
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 5:18 PM ET
Size
18.3 KB